AptaBio Therapeutics Inc. (293780.KQ)

KRW 8040.0

(2.03%)

Eps Summary of AptaBio Therapeutics Inc.

  • AptaBio Therapeutics Inc.'s latest annual eps in 2023 was -540.91 KRW , down -80.69% from previous year.
  • AptaBio Therapeutics Inc.'s latest quarterly eps in 2024 Q1 was -177.89 KRW , up 52.25% from previous quarter.
  • AptaBio Therapeutics Inc. reported an annual eps of -473.98 KRW in 2022, up 33.41% from previous year.
  • AptaBio Therapeutics Inc. reported an annual eps of -711.76 KRW in 2021, down -300.11% from previous year.
  • AptaBio Therapeutics Inc. reported a quarterly eps of -177.89 KRW for 2024 Q1, up 52.25% from previous quarter.
  • AptaBio Therapeutics Inc. reported a quarterly eps of -96.51 KRW for 2023 Q2, up 51.84% from previous quarter.

Annual Eps Chart of AptaBio Therapeutics Inc. (2023 - 2016)

Historical Annual Eps of AptaBio Therapeutics Inc. (2023 - 2016)

Year Eps Eps Growth
2023 -540.91 KRW -80.69%
2022 -473.98 KRW 33.41%
2021 -711.76 KRW -300.11%
2020 -177.89 KRW 38.53%
2019 -289.38 KRW -55.21%
2018 -186.45 KRW -106.68%
2017 -90.21 KRW -132.74%
2016 -38.76 KRW 0.0%

Peer Eps Comparison of AptaBio Therapeutics Inc.

Name Eps Eps Difference
HLB Pharmaceutical Co., Ltd -666.05 KRW 18.788%
CMG Pharmaceutical Co., Ltd. 46.00 KRW 1275.891%
Celltrion Pharm, Inc. 539.00 KRW 200.354%
Huons Global Co., Ltd. 3133.85 KRW 117.26%
DongKook Pharmaceutical Co., Ltd. 1073.13 KRW 150.405%
Enzychem Lifesciences Corporation -109.81 KRW -392.587%
Humedix Co., Ltd. 2512.11 KRW 121.532%
Boditech Med Inc. 1181.00 KRW 145.801%
EuBiologics Co., Ltd. -381.00 KRW -41.971%
FutureChem Co.,Ltd -303.61 KRW -78.159%
Huons Co., Ltd. 4261.00 KRW 112.694%
BNC Korea Co., Ltd. 388.00 KRW 239.41%